Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company reported Q1 2025 revenue of 7.23 billion yuan, a year-on-year increase of 4.9%, but a net profit attributable to shareholders of 310 million yuan, down 18.6% year-on-year [2][5] - The decline in product prices has put pressure on the company's performance, with significant decreases in the sales prices of key products such as glyphosate and organic silicon [11] - The company is expected to benefit from a recovery in product prices and the successful launch of new projects, which will enhance its profitability [11] - The company plans to distribute a cash dividend of 10 yuan per 10 shares, totaling 1.1 billion yuan, which represents a 66.7% increase year-on-year [11] Financial Performance - In Q1 2025, the company's gross margin was 12.9%, down 1.5 percentage points year-on-year, and the net margin was 4.6%, down 0.9 percentage points year-on-year [11] - The company has a production capacity of 230,000 tons per year for glyphosate and 600,000 tons per year for organic silicon, with both products currently at historical low price levels [11] - The company expects net profits attributable to shareholders to be 1.93 billion yuan, 2.53 billion yuan, and 2.94 billion yuan for 2025, 2026, and 2027 respectively [11]

丨证券研究报告丨 [Table_Author] 邬博华 于海宁 曹海花 司鸿历 温筱婷 SAC：S0490514040001 SAC：S0490517110002 SAC：S0490522030001 SAC：S0490520080002 SAC：S0490524100002 SFC：BQK482 SFC：BUX641 SFC：BUD284 联合研究丨公司点评丨科华数据（002335.SZ） [Table_Title] 数据中心弹性初步体现，新能源亏损有望收 窄 报告要点 [Table_Summary] 公司发布 2024 年报及 2025 年一季报，2024 年收入 77.57 亿元，同比-4.71%，实现归母净利 润 3.15 亿元，同比-37.90%，实现扣非净利润 2.85 亿元，同比-38.55%。拆分至单季度，2024 年四季度收入 23.64 亿元，实现归母净利润 0.77 亿元，实现扣非净利润 0.65 亿元；2025 年一 季度收入 12.16 亿元，同比+2.73%，实现归母净利润 0.69 亿元，同比-6.26%，实现扣非净利 润 0.61 亿元，同比+2.06%。 分析师及联系人 请阅 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7] Core Views - The company reported a revenue of 5.385 billion yuan for 2024, an increase of 2.72% year-on-year. However, the net profit attributable to shareholders decreased by 12.60% to 407 million yuan, and the net profit after deducting non-recurring items fell by 48.49% to 175 million yuan. The operating cash flow net amount was 753 million yuan, a slight decrease of 0.22% [2][4] Summary by Sections Financial Performance - In the second half of 2024, the company saw a significant improvement in its operating performance, with revenue increasing by 24.29% compared to the first half. The net profit attributable to shareholders surged by 190.4%, and operating cash flow net amount rose by 61.16%. In Q4 2024, revenue grew by 23.76% year-on-year and 30.67% quarter-on-quarter, while net profit increased by 282.76% year-on-year and 436.76% quarter-on-quarter [10] Business Segments - The smart software business generated revenue of 1.423 billion yuan, a year-on-year increase of 0.49%. The smart automotive business achieved revenue of 2.416 billion yuan, up 3.42% year-on-year. The smart IoT business reported revenue of 1.545 billion yuan, a growth of 3.73% year-on-year, indicating a rebound from the previous year's decline [10] Profitability and Costs - The company's gross margin decreased to 34.29%, down 2.66 percentage points year-on-year. The gross margins for the smart software, smart automotive, and smart IoT businesses were 44.30%, 34.67%, and 18.27%, respectively. The increase in costs and expenses, particularly in R&D, impacted short-term profits [10] Strategic Positioning - The company is focused on its "Operating System + Edge Intelligence" strategy, aiming to leverage its ecosystem advantages and partnerships with leading chip manufacturers and cloud service providers. The company has made significant investments in edge intelligence areas such as industrial robots and AI applications, which are expected to drive future growth [10] Future Outlook - The company is projected to achieve net profits of 482 million yuan, 561 million yuan, and 804 million yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 52, 45, and 31 times [10]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6] Core Views - The company reported a total revenue of 13.3 billion yuan for 2024, a year-on-year decrease of 23.2%. The net profit attributable to shareholders was 490 million yuan, down 6.3% year-on-year, while the net profit excluding non-recurring items was 450 million yuan, a decline of 4.1% year-on-year [2][4] - In Q4 2024, the company achieved a revenue of 3.41 billion yuan, a year-on-year decrease of 18.5% and a quarter-on-quarter decrease of 4.7%. The net profit attributable to shareholders was 130 million yuan, an increase of 10.0% year-on-year but a decrease of 1.4% quarter-on-quarter [2][4] - For Q1 2025, the company reported a revenue of 2.98 billion yuan, down 9.8% year-on-year and 12.8% quarter-on-quarter. The net profit attributable to shareholders was 120 million yuan, an increase of 4.8% year-on-year but a decrease of 7.8% quarter-on-quarter [2][4] Summary by Sections Sales Performance - The company achieved a sales volume of 98,600 tons for positive materials in 2024, maintaining a growth trend. The sales of ternary materials (including lithium iron phosphate and others) reached 52,400 tons, a year-on-year increase of 40%, driven by the growth of high-end pure electric vehicles. The sales of lithium cobalt oxide were 46,200 tons, up 33.5% year-on-year, mainly benefiting from subsidy policies and demand from AI mobile applications [9] - In Q1 2025, the sales volume of positive materials was 24,800 tons, with lithium cobalt oxide sales at 12,300 tons, a year-on-year increase of 46.55%. Ternary positive sales were 10,900 tons, a year-on-year decrease of 31.53% due to a high base effect from the previous year [9] Profitability - The estimated profit per ton for the company in 2024 faced pressure due to a decline in processing fees for ternary positives and the impact of raw material price drops. The iron lithium business remained in a loss state, while hydrogen materials maintained stability with sales of hydrogen storage alloys at 3,900 tons, a year-on-year increase of 3.73% [9] - The company is expected to achieve a net profit of 740 million yuan in 2025, corresponding to a PE ratio of 28 times, and continues to be recommended [9]

丨证券研究报告丨 联合研究丨公司点评丨赛维时代（301381.SZ） [Table_Title] 赛维时代 2024 年报&2025Q1 点评：硬件去库 对利润端阶段拖累，营运指标逐季度企稳向好 报告要点 [Table_Summary] 2024 年公司实现营业收入 102.75 亿元，同比增加 56.55%，实现归母净利润 2.14 亿元，同比 减少 36.19%。2024Q4 公司实现营业收入 34.74 亿元，同比增加 58.66%；实现归母净利润 0.19 亿元，同比减少 83.46%。2025 年 Q1，公司实现营业收入 24.58 亿元，同比增加 36.65%； 实现归母净利润 0.47 亿元，同比减少 45.35%。 分析师及联系人 [Table_Author] 李锦 于旭辉 罗祎 秦意昂 SAC：S0490514080004 SAC：S0490518020002 SAC：S0490520080019 SAC：S0490524110002 SFC：BUV258 SFC：BUU942 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 赛维时代（3013 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [5]. Core Views - The company reported a revenue of 35.392 billion yuan in 2024, representing a year-on-year growth of 11.98%. The net profit attributable to shareholders was 1.207 billion yuan, up 28.56% year-on-year, while the non-recurring net profit reached 263 million yuan, showing a significant increase of 125.86% [3][10]. - In Q4 2024, the company achieved a revenue of 10.217 billion yuan, a growth of 3.97% year-on-year, with a net profit of 794 million yuan, up 22.88% year-on-year, and a non-recurring net profit of 205 million yuan, increasing by 213.66% [3][10]. - For Q1 2025, the company reported a revenue of 9.055 billion yuan, reflecting a year-on-year growth of 20.61%, with a net profit of 101 million yuan, up 45.55% year-on-year, and a non-recurring net profit of 15 million yuan, increasing by 37.59% [3][10]. Summary by Sections Sales and Profitability - The company achieved a total lithium-ion battery sales volume of 19.75 billion ampere-hours in 2024, marking a year-on-year increase of 40.38%, driven by strong market demand [10]. - The overall gross margin for 2024 was 18%, an increase of 2.23 percentage points year-on-year. The gross margin for the power battery system was 15.14%, up 1.33 percentage points, while the gross margin for the energy storage battery system reached 21.75%, an increase of 4.64 percentage points [10]. Cost and Expenses - The total expense ratio for 2024 was 14.76%, a slight increase of 0.09 percentage points year-on-year. The sales expense ratio decreased to 0.86%, down 0.07 percentage points, while the management expense ratio was 5.45%, down 0.05 percentage points [10]. Future Outlook - The company is expected to continue upgrading its product and customer structure in the domestic power market, enhancing its market share and profitability through partnerships with B-class vehicle customers. The expansion of production capacity in overseas markets, including the U.S., Czech Republic, and Morocco, is also anticipated to contribute positively [10].

Investment Rating - The investment rating for the company is "Buy" and it is maintained [6]. Core Views - The company reported a Q1 2025 revenue of 120 million yuan, representing a year-on-year growth of 5.5% but a quarter-on-quarter decline of 7.6%. The net profit attributable to the parent company was -20 million yuan, with a non-recurring net profit also at -20 million yuan [2][4]. - The company’s gross margin for Q1 2025 reached 16.13%, an increase of 1.19 percentage points year-on-year, but a decrease of 1.59 percentage points quarter-on-quarter. The total expense ratio for Q1 2025 was 35.15%, down 1.84 percentage points year-on-year but up 5.50 percentage points quarter-on-quarter [11]. - The company is expected to maintain a high growth rate in the sales of its products, particularly the barium titanate, and the optimization of the sales structure is anticipated to drive profit recovery. New materials such as thermal conductive aluminum and flame retardant materials are expected to contribute to performance growth in 2025 [11]. Summary by Sections Revenue Performance - In Q1 2025, the company achieved a revenue of 120 million yuan, with a year-on-year increase of 5.5% and a quarter-on-quarter decrease of 7.6%. The significant growth in lithium battery coating materials contributed to this performance [2][4][11]. Profitability Analysis - The gross margin for Q1 2025 was 16.13%, reflecting a year-on-year improvement of 1.19 percentage points. However, the margin decreased by 1.59 percentage points compared to the previous quarter. The expense ratio was 35.15%, showing a year-on-year decline but a quarter-on-quarter increase [11]. Future Outlook - The company is expected to see continued growth in the sales of barium titanate, with a stable sales structure likely to enhance profitability. Additionally, the solid oxide fuel cell and high-purity quartz sand are projected to achieve small-scale sales in 2025, further validating the material platform strategy [11].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a significant year-on-year increase in Q1 2025 revenue, reaching 2.73 billion yuan, which is a 17.2% increase compared to the previous year and a 1.1% increase from the previous quarter. However, the net profit attributable to shareholders decreased by 83.6% year-on-year to 30 million yuan, although it turned profitable compared to the previous quarter. The non-recurring net profit also saw a decline of 80.4% year-on-year, also turning profitable quarter-on-quarter [2][4]. Summary by Sections Revenue and Profitability - In Q1 2025, the company's revenue was 2.73 billion yuan, reflecting a 17.2% year-on-year growth and a 1.1% quarter-on-quarter growth. The net profit attributable to shareholders was 30 million yuan, down 83.6% year-on-year but improved from a loss in the previous quarter. The non-recurring net profit also decreased by 80.4% year-on-year, yet showed a quarter-on-quarter recovery [2][4]. Cost and Expenses - The company experienced a significant increase in its expense ratios, with total expenses reaching 17.08% of revenue in Q1 2025, up 2.09 percentage points year-on-year but down 2.53 percentage points quarter-on-quarter. The sales expense ratio was 1.30%, up 0.52 percentage points year-on-year, while the management expense ratio was 6.97%, up 1.30 percentage points year-on-year [9]. Future Outlook - The company is expected to maintain positive growth in shipments throughout the year. Current prices are stabilizing, and there is a low likelihood of significant downward adjustments. The company has signed procurement agreements with LGES and Weilan, which may help expand its overseas market and solid-state applications. The introduction of new products such as solid-state electrolytes and electrolyte membranes is anticipated to enhance profitability [9].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 42.24 CNY based on a reasonable valuation level of 24 times the earnings per share for 2025 [2][5]. Core Views - The company is entering a harvest period for innovative drugs, although its main business faces short-term pressure due to the impact of centralized procurement on the infusion and generic drug segments [1]. - The company achieved a revenue of 21.81 billion CNY in 2024, reflecting a growth of 1.67%, and a net profit attributable to the parent company of 2.94 billion CNY, up 19.53% [9]. - The first quarter of 2025 saw a revenue decline to 4.39 billion CNY, down 29.42%, and a net profit of 584 million CNY, down 43.07%, primarily due to high base effects from the previous year [9]. - The ADC platform is expected to yield significant commercial results, with key products like SKB264 receiving regulatory approval for multiple indications [9]. - The antibiotic supply-demand structure remains stable, with synthetic biology products contributing to revenue growth [9]. Financial Summary - The company’s projected financials indicate a revenue increase from 21.45 billion CNY in 2023 to 29.19 billion CNY by 2027, with a compound annual growth rate of approximately 13% [4]. - The net profit attributable to the parent company is expected to grow from 2.46 billion CNY in 2023 to 3.62 billion CNY in 2027, with a notable increase in 2024 [4]. - Earnings per share are projected to be 1.76 CNY in 2025, with a gradual increase to 2.27 CNY by 2027 [4][2]. - The gross margin is expected to stabilize around 50% to 52.7% over the forecast period, indicating a solid profitability outlook [4].

北交所信息更新 国内浸没式液冷技术领军者，积极布局海外&冷板液冷市场 ——北交所信息更新 2025 年 05 月 25 日 投资评级：增持（维持） | 日期 | 2025/5/23 | | --- | --- | | 当前股价(元) | 50.60 | | 一年最高最低(元) | 86.49/25.00 | | 总市值(亿元) | 101.20 | | 流通市值(亿元) | 98.47 | | 总股本(亿股) | 2.00 | | 流通股本(亿股) | 1.95 | | 近 3 个月换手率(%) | 91.69 | 北交所研究团队 诸海滨（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 2025Q1 实现营收 1166.97 万元（-1.37%），归母净利润-3137.25 万元（-329.66%） 曙光数创 2025Q1 实现营收 1166.97 万元（-1.37%），归母净利-3137.25 万元 （-329.66%）。2024 年实现营收 5.06 亿元（-22.15%）；归母净利润 6142.44 万元 （-41.21%），毛利率为 30.10%（-1.27pc ...